Inrebic

Description

Inrebic is used to treat disease-related splenomegaly or symptoms of primary myelofibrosis, or secondary myelofibrosis due to polycythemia vera or essential thrombocythemia, in adult patients who have not previously received or have been treated with Janus kinase (JAK) inhibitors ruxolitinib.

Active ingredient: fedratinib

Prescription medicine